Value-Based Healthcare (VBHC) defines value as patient-relevant outcomes achieved per unit of cost. Applied to procurement, it changes the central question from 'what does this implant cost?' to 'what outcome does it deliver, at what total cost across the whole episode of care?' For procurement leaders, hospital management and surgeons alike, this shift is no longer theoretical. It is already running in European hospitals, and the early evidence is promising.

From Price to Outcomes

The fiscal logic is straightforward. The Organisation for Economic Co-operation and Development (OECD) estimates that European arthroplasty volumes could double by 2050, and that a significant proportion of current procedures may not be clinically appropriate, whilst a substantial share of patients report dissatisfaction with their outcomes. Paying for activity alone is unsustainable. Paying for value is not only more equitable; it is more efficient.

A major EU-funded initiative, Value-Based Procurement Orthopaedics (VBPO), coordinated by EIT Health and involving hospitals in France, Denmark and Spain, is piloting this model for joint replacement implants. Compensation is linked to patient-centred outcomes through clinician-reported, patient-reported and patient-experience measures, targeting cost efficiency gains of 8% to 20% and potential savings of EUR 300 million in participating countries.

Vejle Hospital: Proof of Concept

One of the most prominent examples of outcome-based procurement in practice comes from Denmark. Vejle Hospital has operated an outcome-based supplier contract for Primary Total Knee Arthroplasty (TKA) implants since 2018. The supplier receives a 17% bonus or penalty based on patient-reported outcomes, length of stay, readmissions and revision rates. After five years, device-related readmission rates fell from 2.4% to 1.2%, patient satisfaction scores rose, and functional improvement reached statistical significance. When procurement aligns with outcomes, the hospital, the supplier and the patient all benefit.

You Can Only Improve What You Can See

Outcome-based procurement depends on reliable data, and orthopaedics is fortunate to possess some of the most mature registries in medicine. Three European programmes illustrate the accountability that standardised measurement creates.

The Dutch Arthroplasty Register (LROI) showed that hospitals receiving monthly outcome feedback achieved significantly better patient results (odds ratio 1.24), and that closing performance gaps across outlier hospitals could have prevented hundreds of unnecessary revisions. Germany's EndoCert certification programme drove preoperative planning compliance from 63% to 96%, improving care quality without compromising outcomes. The UK's Getting It Right First Time (GIRFT) initiative achieved a 58% reduction in pre-TKA arthroscopy and length-of-stay reductions of more than one day across hip and knee procedures.

Taken together, these initiatives suggest that standardised measurement can improve transparency and support quality improvement efforts.

Standardisation: The Essential Foundation

VBHC cannot function without comparable, reliable data, and that data cannot exist without standardised care. Standardised clinical protocols create the measurable baseline that makes outcome recording possible, enable meaningful benchmarking between institutions, and lay the groundwork for continuous improvement. For procurement leaders, standardisation is the precondition for any outcome-based contract. For surgeons, it is what makes fair comparison possible. For management, it converts registry feedback into operational gains.

Zimmer Biomet's Efficient Care programmes are built on this principle. At a large public hospital in the Netherlands, structured pathway standardisation reduced average length of stay by 38% with no increase in readmissions or complications. These are not only operational achievements - they are the building blocks of a credible value case.

The value equation is being rewritten across European orthopaedics. The hospitals and systems that thrive will be those that build the data infrastructure now. Standardised pathways, embedded outcome measurement and outcome-based partnerships are no longer aspirational - they are increasingly being adopted across European healthcare systems.